We have studied the efficacy of prolonged, continuous paravertebral infusion of bupivacaine for the management of post-thoracotomy pain in 22 infants with a median age of 1.5 weeks (range 1 day to 20.4 weeks). Immediately before chest closure, 0.25% bupivacaine 1.25 mg kg 91 wasgiven into an extrapleural paravertebral catheter, inserted under direct vision. Subsequently, 0.125% bupivacaine with adrenaline 1:400 000 was infused at a rate of 0.2 ml kg 91 h 91 for 48 h. We confirmed that extrapleural paravertebral catheter placement under direct vision was easy in neonates and infants. The technique provided effective postoperative pain relief in 86% of patients, with three patients requiring morphine in addition. Mean serum concentration of bupivacaine after 48 h was 1.60 (0.67) g ml
Regional analgesia has become a routine part of the perioperative management of children undergoing thoracic surgery, with both paravertebral 1 and intrapleural 2 infusions of bupivacaine being advocated. However, we believe that paravertebral blocks are inherently safer for small infants because the local anaesthetic is applied more directly onto the appropriate nerve roots and the total drug dose required to provide effective analgesia should be lower than that using the less direct intrapleural approach. Nevertheless, in our previous study of 20 infants receiving an infusion of 0.25% bupivacaine 0.5 mg kg 91 h 91 into the paravertebral space for 24 h, we found significant cumulation of bupivacaine in some patients and maximum serum bupivacaine concentrations approached potentially toxic levels. 1 We hypothesized that the safe duration of postoperative analgesia that could be offered using this technique may be prolonged by reducing the amount of bupivacaine being administered. Furthermore, we hoped that addition of a low concentration of adrenaline to the solution would restrict systemic absorption and thus reduce toxicity potential. The addition of adrenaline to bupivacaine, given by continuous extradural infusion to young children, has been shown to produce significant prolongation of analgesic effect. 3 Therefore, we assessed the analgesic efficacy and measured intermittently serum concentrations of bupivacaine, during infusion of bupivacaine 0.25 mg kg 91 h 91 with adrenaline 1:400 000 for 48 h, into a paravertebral catheter in infants requiring thoracotomy.
Patients and methods
The study was approved by the local Ethics Committee and written, informed parental consent was obtained. We studied 22 infants, 937 to :60 weeks gestational age (neonates included), who were 92.0 kg in weight, undergoing elective or emergency thoracotomy for various cardiac procedures. For 14 infants no premedication was prescribed. I.v. cannulation was performed before anaesthesia which was induced with thiopentone 4 mg kg 91 . Atracurium 0.5 mg kg 91 was used to facilitate tracheal intubation. The remaining eight patients had required preoperative artificial ventilation and an i.v. infusion of morphine 10-20 g kg 91 h
91
, the latter being stopped after induction of anaesthesia. For all patients anaesthesia was maintained subsequently with 0.5% isoflurane and 50-66% nitrous oxide in oxygen, and fentanyl 2 g kg 91 i.v. was used to provide peroperative analgesia. Repeated injections of atracurium 0.25 mg kg 91 were given as necessary to maintain neuromuscular block. Intraarterial and central venous cannulation were used to facilitate arterial pressure monitoring and blood sampling for bupivacaine assays. A blood sample was also obtained after induction of anaesthesia for baseline measurement of serum bupivacaine concentration (zero control).
When the surgical procedure was completed, just before chest closure, the parietal pleura was peeled medially starting at the thoracotomy space. The resulting pocket was extended from the posterior wound margin onto the vertebral bodies and for two intercostal spaces above and below using a Lahey's forceps to create a tunnel in the paravertebral space. A Tuohy needle was inserted percutaneously at a site close to the angle of the rib, near the incision, to emerge near the extrapleural pocket created earlier.
The stylet was removed and a side holed (od 0.9 mm) extradural catheter (Minipack, Portex Ltd) was advanced through the needle and positioned cranially under direct vision such that approximately 3 cm of its length lay against the costo-vertebral joints within the pocket, as described previously. 1 The needle was removed and the parietal pleura was re-attached, along the posterior edge of the wound, before the thorax was closed. The catheter was aspirated and a test dose of 0.125% bupivacaine 1.0-1.5 ml with adrenaline 1:400 000 was administered through a bacterial filter. If haemodynamic variables remained stable, a loading dose of 0.25% bupivacaine 0.5 ml kg 91 (1.25 mg kg
) was injected into the catheter over 1 min. An infusion of 0.125% bupivacaine with adrenaline 1:400 000 at a rate of 0.2 ml kg 91 h 91 (0.25 mg kg 91 h
) was then started and continued for 48 h at the same rate.
All patients were nursed after operation in the ICU and the trachea was extubated when spontaneous ventilation was deemed adequate and there were no medical or surgical contraindications. Before extubation, a simplified CRIES pain score 4 , excluding the crying variable, was performed by an ICU nurse as part of the routine hourly observations. When the trachea was extubated, assessments of postoperative pain were made using the full CRIES pain scale, although throughout the study the scoring for "requirement for oxygen" was modified such that the expected (baseline) oxygen saturation achieved during anaesthesia after surgery, with 30-50% oxygen, was used to assess subsequent changes in oxygen requirements required to achieve this baseline level. In the first 24 h after operation an i.v. infusion of morphine 10 g kg 91 h 91 was prescribed as "rescue analgesia" but given only if a pain score 93/10 was observed and could not be reduced by a dummy or feeding. Every patient was given paracetamol 15 mg kg 91 via a nasogastric tube, every 6 h, from 24 to 72 h after operation.
Blood samples were obtained from a central venous or arterial cannula at 6-hourly intervals after starting the infusion, for subsequent measurement of serum concentrations of bupivacaine. An additional sample was obtained 6 h after stopping the infusion. Blood samples were centrifuged, serum separated and stored at 920ЊC before assay. Serum concentrations of bupivacaine were measured by reverse phase high pressure liquid chromatography, as described previously. 
Results
Patient age, weight and operations are shown in table 1. Median age was 1.5 (0.1-20.4) weeks and median weight 3.2 (2.5-5.5) kg. Insertion of the extradural paravertebral catheter was not technically difficult, even in the smallest neonate. There were no major complications or adverse haemodynamic effects related to either catheter insertion or production of paravertebral block in any patient. Two patients had significant leakage of pleural fluid at the skin entry point of the paravertebral catheter, without compromise to analgesia. Another two patients had transient, accidental disconnection of the infusion. In seven babies the trachea was extubated within 1 h of surgery; in the other 15 babies the trachea remained intubated (without paralysis) for a median time of 24.0 (3-48) h after surgery.
One patient was given morphine soon after return to the ICU because extra sedation and analgesia were needed during treatment of surgical Figure 1 Mean (SD) serum bupivacaine concentrations during infusion.
complications. In 18 patients the median mean hourly pain score was 0.29 (0.00-1.63); three patients had pain scores 93/10 and required morphine as rescue analgesia soon after operation. In one of these three patients a short period of accidental disconnection was associated with low bupivacaine concentrations. A second patient was subsequently diagnosed, by endoscopy, to have had severe gastritis. There was no obvious reason why the block did not work in the third patient.
Technical problems prevented sampling in one patient. There was a progressive increase in serum bupivacaine concentrations during the infusion period in most patients ( fig. 1) 
Discussion
We have confirmed that direct placement of a paravertebral catheter at the time of a thoracotomy was simple, even in small neonates. Continuous infusion of bupivacaine into the catheter provided good analgesia in the great majority of patients for 48 h after operation. However, the analgesic efficacy of the technique was slightly less than that found in our previous study, where we used a higher dose of bupivacaine. 1 Four patients (18.2%) required morphine as additional analgesia during the early postoperative period, although one of these received morphine not because of block failure but because of surgical complications requiring immediate intervention.
The highest serum bupivacaine concentration reported in our previous study of similar aged infants, using an infusion of bupivacaine 0.5 mg kg 91 h 91 for 24 h, was 3.14 g ml
91
, with a mean maximum concentration of 2.0 g ml 91 . 1 We believe that these bupivacaine concentrations are potentially toxic [5] [6] [7] [8] [9] [10] and, as we wished to provide effective analgesia for at least 48 h without undue risk, we used an infusion at half the original drug concentration, although with the same infusion rate, and with the addition of adrenaline. This new dosage regimen is similar to that suggested for caudal extradural analgesia in infants. 11 We used the same loading dose of 0.25% bupivacaine as in our previous study (1.25 ) appears necessary to cover reliably at least five intercostal segments, which is usually required for adequate post-thoracotomy analgesia. 12 In this study the reduced bupivacaine dosage resulted in maximum serum concentrations that were well below potentially toxic concentrations in 18 infants. However, in three patients bupivacaine concentrations 93 g ml 91 were measured at 30-42 h of infusion. One of the three patients with high bupivacaine concentrations required additional analgesia soon after surgery and perhaps exceptional vascularity of the paravertebral space, resulting in increased systemic absorption, may help explain these unexpected findings. It would appear, therefore, that prolonged infusion of bupivacaine for 930 h in young infants may result in high serum bupivacaine concentrations in a small, but unpredictable, proportion. However, the normal postoperative increase in plasma ␣ 1 -acid glycoprotein (AAG) concentration 13 may limit the potential toxicity of accumulating total bupivacaine by limiting the free bupivacaine concentration.
14 However, the relationship between plasma AAG concentration, unbound bupivacaine concentration and toxicity is more complex than is immediately apparent. [14] [15] [16] [17] Bupivacaine has a large volume of distribution (approximately 2.5 litre kg
). 18 Under conditions of near steady state, as when systemic drug absorption is gradual during bupivacaine infusion into the paravertebral space, only a small fraction of total drug dose is confined to the blood. Under these conditions, changes in AAG concentrations may have little impact on toxicity as plasma protein binding does not control access of drug to sites of toxicity.
14 Furthermore, for drugs such as bupivacaine which have a low hepatic extraction ratio, any increase in free drug concentration may be compensated by faster elimination.
Significant differences between arterial and venous local anaesthetic concentrations have been shown within the first hour of a laryngeal spray 19 or single caudal, 20 extradural 21 or intercostal injection. 21 22 This occurs because the lung temporarily sequestrates a large quantity of the local anaesthetic, because of a high lung-blood coefficient, before subsequent release. 16 It follows that patients with intracardiac right-to-left shunts may be at higher risk of CNS toxicity than normal patients, after accidental i.v. injection of bupivacaine. Animal experimental work has supported this premise. 23 24 However, in our study, in all patients with significant right-to-left intracardiac shunting, pulmonary blood flow was at least partially restored by the formation of a subclavian artery-pulmonary artery shunt. More importantly, however, in all of the studies mentioned above reporting simultaneous arterial and venous local anaesthetic concentrations, arterio-venous differences had become insignificant by 30-60 min after injection. In our study, we have postulated that by the time of the first sample at 6 h, near steady state conditions prevailed, and any difference between arterial and central venous bupivacaine concentrations would be insignificant. Bupivacaine binds to erythrocytic components and also plasma proteins, and the blood-plasma bupivacaine concentration ratio () varies with packed cell volume (PCV). 22 However, because of the perioperative transfusion policy, postoperative PCV of our patients did not vary widely (0.33-0.44).
may be related to PCV by the equation :90.0079 PCV;1.028, 22 so that calculated total blood bupivacaine concentrations varied from 23 to 31% higher than our reported serum concentrations. Thus the variation in PCV in our patients resulted in a maximum inaccuracy in calculated total bupivacaine concentrations of approximately 8%. However, by using the same analytical technique as in our first study, we have been able to compare directly our present results with previous data.
We had hypothesized that the provision of adequate postoperative analgesia, without recourse to opioid medication, would enable earlier tracheal extubation than would otherwise have been the case. Eight of the patients we studied required controlled ventilation before operation and, subsequently, for 26.3 (9.4) h after operation. Retrospective data obtained from five consecutive infants having repair of coarctation who required artificial ventilation both before and after operation, but who received morphine for analgesia, showed a mean time to extubation of 46.5 (4.5) h. Although such small numbers make any definitive conclusions unwarranted, we suggest that the duration of postoperative ventilation in infants without other medical or surgical problems may be reduced by using non-opioid rather than opioid analgesia. Seven other patients in our study required postoperative intubation for 3-48 h because of surgical complications, medical problems or excessive tracheal secretions not conducive to early extubation. Despite these babies' tracheas being intubated, our nurses were able to assess facial grimacing, movement and physiological changes, such that pain scores could be assessed.
In our study we found that the technique of continuous extrapleural paravertebral infusion of bupivacaine provided effective analgesia in 86% (18 of 21) of our patients. Our "success" rate is slightly lower than that described in previous studies in infants 1 and children, 25 which used higher doses of bupivacaine. This comparison could be interpreted to indicate that, at least in some of our patients, the dose of bupivacaine administered was too low. If this had not been a research investigation, we would have tried to increase efficacy by increasing the infusion rate, but we did not attempt this strategy in our three "failure" patients, as their serum bupivacaine concentration data would not be comparable. A temporary increase in infusion rate would appear safe within the first 24 h after operation, although after 30 h such a strategy may lead to an increased risk of toxicity. The regular addition of paracetamol would also seem a sensible adjunct to this technique.
Hopefully, in the near future, this useful analgesic technique may be made even safer by the use of ropivacaine rather than bupivacaine. 26 
